Clinical Study About The Effect Of Pulmonary Function Of Bronchial Asthma (Chronic Duration) Treated With Thermal Moxibustion

Objective:Using thermal moxibustion and Seretide asthma (chronic duration) compared to lung function as observed to thermal moxibustion and Seretide intervention on pulmonary function in asthma patients, and compare the differences in clinical optimization provide an objective basis for treatment.Methods:Select chronic persistent asthma 42 patients were randomly divided into thermal moxibustion group and the Seretide group by, were recorded before treatment and at the end of 6 months after treatment pulmonary function indicators, will record the data for statistical analysis.Results:1. Thermal moxibustion group:the end of treatment compared with before treatment, pulmonary function indices were significantly different (p<0.01),6 months after treatment, the lung function indices are significant differences (p<0.01) 2. Shu Lee Diego group:the end of treatment compared with before treatment, pulmonary function indices were significantly different (p<0.01),6 months after treatment compared with before treatment, lung function showed no significant difference (p> 0.05).3. Between the two groups:the end of treatment, thermal moxibustion and Seretide was no significant difference (p>0.05), 6 months after treatment, the thermal moxibustion therapy was superior to Seretide therapy (p<0.01).Conclusions:Thermal moxibustion therapy and Seretide therapy can improve lung function in asthma patients, but long-term to improve the situation, thermal moxibustion therapy was superior to Seretide therapy.